-+ 0.00%
-+ 0.00%
-+ 0.00%

Market Chatter: AstraZeneca Submits $10 Billion Takeover Offer for Rhythm Pharmaceuticals

MT Newswires·11/04/2026 23:30:58
Listen to the news
11:30 PM EST, 11/04/2026 (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) offered $124 per share to take over biotechnology company Rhythm Pharmaceuticals, The Wall Street Journal reported Wednesday, citing people familiar with the matter. The unnamed sources said the offer came in October, after the British drugmaker previously expressed interest in Rhythm. The report noted that the proposal valued the target company at roughly $10 billion. AstraZeneca and Rhythm Pharmaceuticals did not immediately respond to requests for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)